Catheter Related Bloodstream Infections (CRBSIs) Market By Type (Non-antibiotic, Antibiotic, Others), By Route Of Administration (Oral and Intravenous), By Source of Infection/Causative Agents (Staphylococcus aureus, P. Aeruginsa, Acinetobacter Baumannii, E. Coli, K. Pneuminiae, Candida Sp., Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Catheter-Related Bloodstream Infections (CRBSIs) Market size was valued at USD 1.4 billion in 2022 and is poised to grow at a significant CAGR of 5.1% during 2023-2029. The global market is predicted to be driven by an increase in the prevalence of bloodstream infections. According to a study in the journal Continuing Education in Anaesthesia, Critical Care & Pain, catheter-related bloodstream infections happen in about 3% of catheterizations, although they can happen up to 16% of the time. Inaccurate diagnoses have serious consequences, including procedure difficulties that raise morbidity and mortality. Therefore, it is crucial to identify catheter-related bloodstream infections accurately. Moreover, the risk of CRBSI is elevated by hospital-acquired infections. According to the International Journal of Critical Illness and Injury Science, 10 to 20 percent of hospital-acquired infections in the United Kingdom are caused by CRBSI. The infrastructure for health care is being modernized by governments in developing nations, which is anticipated to expand access to healthcare. Additionally, healthcare-associated infections are a significant problem in underdeveloped countries. Therefore, the global market is presented with a huge potential due to the rise in demand for the items brought on by the patient population growth.

Catheter Related Bloodstream Infections Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.5%

Largest Market

Asia-Pacific

Fastest Growing Market

North America
Catheter-Related Bloodstream Infections Market Dynamics

The patient is more likely to develop CRBSI if they have immunosuppression, whether it is absolute (like that seen in the critically ill) or relative (like that found in diseases of the blood). The rate of CRBSI is also influenced by the microbiological environment, with higher rates in the intensive care unit than in the outpatient setting. The injection of TPN, frequent catheter access, and improper aseptic procedures are risk factors for CRBSI. The increasing risk of CRBSI is driving the market worldwide. On the other hand, regulations related to culture media and micro-organisms in laboratories restrain the market.

Key Features of the Reports

  • The catheter related bloodstream infections market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Catheter Related Bloodstream Infections Market Segmentation

By Type
  • Non-antibiotic
  • Antibiotic
  • Others
By Administration
  • Oral
  • Intravenous
By Source Of Infection
  • Staphylococcus aureus
  • aeruginsa
  • Acinetobacter baumannii
  • Coli
  • Pneuminiae
  • Candida Sp.
  • Others

Frequently Asked Questions

The catheter-related bloodstream infections market is projected to expand at a CAGR of 5.1% during the forecast period

CorMedix, Inc., Geistlich Pharma, TauroPharm GmbH, Fresenius Medical Care, Citius Pharmaceuticals

North America is the fastest-growing region for catheter-related bloodstream infections market

1.Executive Summary
2.Global Catheter Related Bloodstream Infections Market Introduction 
2.1.Global Catheter Related Bloodstream Infections Market  - Taxonomy
2.2.Global Catheter Related Bloodstream Infections Market  - Definitions
2.2.1.Type 
2.2.2.Administration
2.2.3. Source Of Infection
2.2.4.Region
3.Global Catheter Related Bloodstream Infections Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Catheter Related Bloodstream Infections Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Catheter Related Bloodstream Infections Market  By Type , 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Non-antibiotic
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Antibiotic
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Catheter Related Bloodstream Infections Market  By Administration, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Oral
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Intravenous
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
7.Global Catheter Related Bloodstream Infections Market  By  Source Of Infection, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Staphylococcus aureus
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. aeruginsa
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Acinetobacter baumannii
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Coli
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Pneuminiae
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Candida Sp.
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Others
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
8.Global Catheter Related Bloodstream Infections Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Catheter Related Bloodstream Infections Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Non-antibiotic
9.1.2.Antibiotic
9.1.3.Others
9.2.  Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oral
9.2.2.Intravenous
9.3.   Source Of Infection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Staphylococcus aureus
9.3.2.aeruginsa
9.3.3.Acinetobacter baumannii
9.3.4.Coli
9.3.5.Pneuminiae
9.3.6.Candida Sp.
9.3.7.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Catheter Related Bloodstream Infections Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Non-antibiotic
10.1.2.Antibiotic
10.1.3.Others
10.2.  Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oral
10.2.2.Intravenous
10.3.   Source Of Infection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Staphylococcus aureus
10.3.2.aeruginsa
10.3.3.Acinetobacter baumannii
10.3.4.Coli
10.3.5.Pneuminiae
10.3.6.Candida Sp.
10.3.7.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Catheter Related Bloodstream Infections Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Non-antibiotic
11.1.2.Antibiotic
11.1.3.Others
11.2.  Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oral
11.2.2.Intravenous
11.3.   Source Of Infection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Staphylococcus aureus
11.3.2.aeruginsa
11.3.3.Acinetobacter baumannii
11.3.4.Coli
11.3.5.Pneuminiae
11.3.6.Candida Sp.
11.3.7.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Catheter Related Bloodstream Infections Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Non-antibiotic
12.1.2.Antibiotic
12.1.3.Others
12.2.  Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oral
12.2.2.Intravenous
12.3.   Source Of Infection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Staphylococcus aureus
12.3.2.aeruginsa
12.3.3.Acinetobacter baumannii
12.3.4.Coli
12.3.5.Pneuminiae
12.3.6.Candida Sp.
12.3.7.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Catheter Related Bloodstream Infections Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type  Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Non-antibiotic
13.1.2.Antibiotic
13.1.3.Others
13.2.  Administration Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oral
13.2.2.Intravenous
13.3.   Source Of Infection Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Staphylococcus aureus
13.3.2.aeruginsa
13.3.3.Acinetobacter baumannii
13.3.4.Coli
13.3.5.Pneuminiae
13.3.6.Candida Sp.
13.3.7.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Merck Sharp 
14.2.2.Dohme Corp
14.2.3.CorMedix, Inc.
14.2.4.Geistlich Pharma
14.2.5.TauroPharm GmbH
14.2.6.Fresenius Medical Care
14.2.7.Citius Pharmaceuticals
15. Research Methodology 
16. Appendix and Abbreviations 
  • Merck Sharp 
  • Dohme Corp
  • CorMedix, Inc.
  • Geistlich Pharma
  • TauroPharm GmbH
  • Fresenius Medical Care
  • Citius Pharmaceuticals

Adjacent Markets